Cargando…
The Combination of Marketed Antagonists of α1b-Adrenergic and 5-HT2A Receptors Inhibits Behavioral Sensitization and Preference to Alcohol in Mice: A Promising Approach for the Treatment of Alcohol Dependence
Alcohol-dependence is a chronic disease with a dramatic and expensive social impact. Previous studies have indicated that the blockade of two monoaminergic receptors, α1b-adrenergic and 5-HT2A, could inhibit the development of behavioral sensitization to drugs of abuse, a hallmark of drug-seeking an...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788426/ https://www.ncbi.nlm.nih.gov/pubmed/26968030 http://dx.doi.org/10.1371/journal.pone.0151242 |
_version_ | 1782420729170493440 |
---|---|
author | Trovero, Fabrice David, Sabrina Bernard, Philippe Puech, Alain Bizot, Jean-Charles Tassin, Jean-Pol |
author_facet | Trovero, Fabrice David, Sabrina Bernard, Philippe Puech, Alain Bizot, Jean-Charles Tassin, Jean-Pol |
author_sort | Trovero, Fabrice |
collection | PubMed |
description | Alcohol-dependence is a chronic disease with a dramatic and expensive social impact. Previous studies have indicated that the blockade of two monoaminergic receptors, α1b-adrenergic and 5-HT2A, could inhibit the development of behavioral sensitization to drugs of abuse, a hallmark of drug-seeking and drug-taking behaviors in rodents. Here, in order to develop a potential therapeutic treatment of alcohol dependence in humans, we have blocked these two monoaminergic receptors by a combination of antagonists already approved by Health Agencies. We show that the association of ifenprodil (1 mg/kg) and cyproheptadine (1 mg/kg) (α1-adrenergic and 5-HT2 receptor antagonists marketed as Vadilex ® and Periactine ® in France, respectively) blocks behavioral sensitization to amphetamine in C57Bl6 mice and to alcohol in DBA2 mice. Moreover, this combination of antagonists inhibits alcohol intake in mice habituated to alcohol (10% v/v) and reverses their alcohol preference. Finally, in order to verify that the effect of ifenprodil was not due to its anti-NMDA receptors property, we have shown that a combination of prazosin (0.5 mg/kg, an α1b-adrenergic antagonist, Mini-Press ® in France) and cyproheptadine (1 mg/kg) could also reverse alcohol preference. Altogether these findings strongly suggest that combined prazosin and cyproheptadine could be efficient as a therapy to treat alcoholism in humans. Finally, because α1b-adrenergic and 5-HT2A receptors blockade also inhibits behavioral sensitization to psychostimulants, opioids and tobacco, it cannot be excluded that this combination will exhibit some efficacy in the treatment of addiction to other abused drugs. |
format | Online Article Text |
id | pubmed-4788426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47884262016-03-23 The Combination of Marketed Antagonists of α1b-Adrenergic and 5-HT2A Receptors Inhibits Behavioral Sensitization and Preference to Alcohol in Mice: A Promising Approach for the Treatment of Alcohol Dependence Trovero, Fabrice David, Sabrina Bernard, Philippe Puech, Alain Bizot, Jean-Charles Tassin, Jean-Pol PLoS One Research Article Alcohol-dependence is a chronic disease with a dramatic and expensive social impact. Previous studies have indicated that the blockade of two monoaminergic receptors, α1b-adrenergic and 5-HT2A, could inhibit the development of behavioral sensitization to drugs of abuse, a hallmark of drug-seeking and drug-taking behaviors in rodents. Here, in order to develop a potential therapeutic treatment of alcohol dependence in humans, we have blocked these two monoaminergic receptors by a combination of antagonists already approved by Health Agencies. We show that the association of ifenprodil (1 mg/kg) and cyproheptadine (1 mg/kg) (α1-adrenergic and 5-HT2 receptor antagonists marketed as Vadilex ® and Periactine ® in France, respectively) blocks behavioral sensitization to amphetamine in C57Bl6 mice and to alcohol in DBA2 mice. Moreover, this combination of antagonists inhibits alcohol intake in mice habituated to alcohol (10% v/v) and reverses their alcohol preference. Finally, in order to verify that the effect of ifenprodil was not due to its anti-NMDA receptors property, we have shown that a combination of prazosin (0.5 mg/kg, an α1b-adrenergic antagonist, Mini-Press ® in France) and cyproheptadine (1 mg/kg) could also reverse alcohol preference. Altogether these findings strongly suggest that combined prazosin and cyproheptadine could be efficient as a therapy to treat alcoholism in humans. Finally, because α1b-adrenergic and 5-HT2A receptors blockade also inhibits behavioral sensitization to psychostimulants, opioids and tobacco, it cannot be excluded that this combination will exhibit some efficacy in the treatment of addiction to other abused drugs. Public Library of Science 2016-03-11 /pmc/articles/PMC4788426/ /pubmed/26968030 http://dx.doi.org/10.1371/journal.pone.0151242 Text en © 2016 Trovero et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Trovero, Fabrice David, Sabrina Bernard, Philippe Puech, Alain Bizot, Jean-Charles Tassin, Jean-Pol The Combination of Marketed Antagonists of α1b-Adrenergic and 5-HT2A Receptors Inhibits Behavioral Sensitization and Preference to Alcohol in Mice: A Promising Approach for the Treatment of Alcohol Dependence |
title | The Combination of Marketed Antagonists of α1b-Adrenergic and 5-HT2A Receptors Inhibits Behavioral Sensitization and Preference to Alcohol in Mice: A Promising Approach for the Treatment of Alcohol Dependence |
title_full | The Combination of Marketed Antagonists of α1b-Adrenergic and 5-HT2A Receptors Inhibits Behavioral Sensitization and Preference to Alcohol in Mice: A Promising Approach for the Treatment of Alcohol Dependence |
title_fullStr | The Combination of Marketed Antagonists of α1b-Adrenergic and 5-HT2A Receptors Inhibits Behavioral Sensitization and Preference to Alcohol in Mice: A Promising Approach for the Treatment of Alcohol Dependence |
title_full_unstemmed | The Combination of Marketed Antagonists of α1b-Adrenergic and 5-HT2A Receptors Inhibits Behavioral Sensitization and Preference to Alcohol in Mice: A Promising Approach for the Treatment of Alcohol Dependence |
title_short | The Combination of Marketed Antagonists of α1b-Adrenergic and 5-HT2A Receptors Inhibits Behavioral Sensitization and Preference to Alcohol in Mice: A Promising Approach for the Treatment of Alcohol Dependence |
title_sort | combination of marketed antagonists of α1b-adrenergic and 5-ht2a receptors inhibits behavioral sensitization and preference to alcohol in mice: a promising approach for the treatment of alcohol dependence |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788426/ https://www.ncbi.nlm.nih.gov/pubmed/26968030 http://dx.doi.org/10.1371/journal.pone.0151242 |
work_keys_str_mv | AT troverofabrice thecombinationofmarketedantagonistsofa1badrenergicand5ht2areceptorsinhibitsbehavioralsensitizationandpreferencetoalcoholinmiceapromisingapproachforthetreatmentofalcoholdependence AT davidsabrina thecombinationofmarketedantagonistsofa1badrenergicand5ht2areceptorsinhibitsbehavioralsensitizationandpreferencetoalcoholinmiceapromisingapproachforthetreatmentofalcoholdependence AT bernardphilippe thecombinationofmarketedantagonistsofa1badrenergicand5ht2areceptorsinhibitsbehavioralsensitizationandpreferencetoalcoholinmiceapromisingapproachforthetreatmentofalcoholdependence AT puechalain thecombinationofmarketedantagonistsofa1badrenergicand5ht2areceptorsinhibitsbehavioralsensitizationandpreferencetoalcoholinmiceapromisingapproachforthetreatmentofalcoholdependence AT bizotjeancharles thecombinationofmarketedantagonistsofa1badrenergicand5ht2areceptorsinhibitsbehavioralsensitizationandpreferencetoalcoholinmiceapromisingapproachforthetreatmentofalcoholdependence AT tassinjeanpol thecombinationofmarketedantagonistsofa1badrenergicand5ht2areceptorsinhibitsbehavioralsensitizationandpreferencetoalcoholinmiceapromisingapproachforthetreatmentofalcoholdependence AT troverofabrice combinationofmarketedantagonistsofa1badrenergicand5ht2areceptorsinhibitsbehavioralsensitizationandpreferencetoalcoholinmiceapromisingapproachforthetreatmentofalcoholdependence AT davidsabrina combinationofmarketedantagonistsofa1badrenergicand5ht2areceptorsinhibitsbehavioralsensitizationandpreferencetoalcoholinmiceapromisingapproachforthetreatmentofalcoholdependence AT bernardphilippe combinationofmarketedantagonistsofa1badrenergicand5ht2areceptorsinhibitsbehavioralsensitizationandpreferencetoalcoholinmiceapromisingapproachforthetreatmentofalcoholdependence AT puechalain combinationofmarketedantagonistsofa1badrenergicand5ht2areceptorsinhibitsbehavioralsensitizationandpreferencetoalcoholinmiceapromisingapproachforthetreatmentofalcoholdependence AT bizotjeancharles combinationofmarketedantagonistsofa1badrenergicand5ht2areceptorsinhibitsbehavioralsensitizationandpreferencetoalcoholinmiceapromisingapproachforthetreatmentofalcoholdependence AT tassinjeanpol combinationofmarketedantagonistsofa1badrenergicand5ht2areceptorsinhibitsbehavioralsensitizationandpreferencetoalcoholinmiceapromisingapproachforthetreatmentofalcoholdependence |